A citation-based method for searching scientific literature

Melissa Martyn, Anaita Kanga-Parabia, Elly Lynch, Paul A James, Ivan Macciocca, Alison H Trainer, Jane Halliday, Louise Keogh, Janney Wale, Ingrid Winship, Michael Bogwitz, Giulia Valente, Maie Walsh, Lilian Downie, David Amor, Mathew Wallis, Fiona Cunningham, Matthew Burgess, Natasha J Brown, Anna Jarmolowicz, Sebastian Lunke, Ilias Goranitis, Clara L Gaff. J Genet Couns 2019
Times Cited: 2







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations.
Pascal Pujol, Pierre Vande Perre, Laurence Faivre, Damien Sanlaville, Carole Corsini, Bernard Baertschi, Michèle Anahory, Dominique Vaur, Sylviane Olschwang, Nadem Soufir,[...]. Eur. J. Hum. Genet. 2018
9
100

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet. Med. 2017
592
100

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet. Med. 2013
100

Recommendations for returning genomic incidental findings? We need to talk!
Wylie Burke, Armand H Matheny Antommaria, Robin Bennett, Jeffrey Botkin, Ellen Wright Clayton, Gail E Henderson, Ingrid A Holm, Gail P Jarvik, Muin J Khoury, Bartha Maria Knoppers,[...]. Genet. Med. 2013
191
100

Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
M Ragan Hart, Barbara B Biesecker, Carrie L Blout, Kurt D Christensen, Laura M Amendola, Katie L Bergstrom, Sawona Biswas, Kevin M Bowling, Kyle B Brothers, Laura K Conlin,[...]. Genet. Med. 2019
32
100

Reconciling Opportunistic and Population Screening in Clinical Genomics.
Kyle B Brothers, Jason L Vassy, Robert C Green. Mayo Clin. Proc. 2019
8
100



Assessing the Costs and Cost-Effectiveness of Genomic Sequencing.
Kurt D Christensen, Dmitry Dukhovny, Uwe Siebert, Robert C Green.  2015
51
50

Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.
Jeffrey R Botkin, John W Belmont, Jonathan S Berg, Benjamin E Berkman, Yvonne Bombard, Ingrid A Holm, Howard P Levy, Kelly E Ormond, Howard M Saal, Nancy B Spinner,[...]. Am. J. Hum. Genet. 2015
180
50



Actionable, pathogenic incidental findings in 1,000 participants' exomes.
Michael O Dorschner, Laura M Amendola, Emily H Turner, Peggy D Robertson, Brian H Shirts, Carlos J Gallego, Robin L Bennett, Kelly L Jones, Mari J Tokita, James T Bennett,[...]. Am. J. Hum. Genet. 2013
245
50

Overview of parametric survival analysis for health-economic applications.
K Jack Ishak, Noemi Kreif, Agnes Benedict, Noemi Muszbek. Pharmacoeconomics 2013
32
50

A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy.
Max Catchpool, Jay Ramchand, Melissa Martyn, David L Hare, Paul A James, Alison H Trainer, Josh Knight, Ilias Goranitis. Genet Med 2019
4
50

The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.
Caroline S Bennette, Carlos J Gallego, Wylie Burke, Gail P Jarvik, David L Veenstra. Genet. Med. 2015
50
50

Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer.
Erin Tutty, Lara Petelin, Joanne McKinley, Mary-Anne Young, Bettina Meiser, Victoria M Rasmussen, Rowan Forbes Shepherd, Paul A James, Laura E Forrest. Eur. J. Hum. Genet. 2019
2
50

Return of individual genomic research results: are laws and policies keeping step?
Adrian Thorogood, Gratien Dalpé, Bartha Maria Knoppers. Eur. J. Hum. Genet. 2019
16
50

Clinical integration of next generation sequencing: coverage and reimbursement challenges.
Patricia A Deverka, Jennifer C Dreyfus. J Law Med Ethics 2014
32
50

Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement.
Zornitza Stark, Deborah Schofield, Khurshid Alam, William Wilson, Nessie Mupfeki, Ivan Macciocca, Rupendra Shrestha, Susan M White, Clara Gaff. Genet. Med. 2017
84
50

Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review.
Michael P Douglas, Uri Ladabaum, Mark J Pletcher, Deborah A Marshall, Kathryn A Phillips. Genet. Med. 2016
15
50

Is "incidental finding" the best term?: a study of patients' preferences.
Nina Tan, Laura M Amendola, Julianne M O'Daniel, Amber Burt, Martha J Horike-Pyne, Lacey Boshe, Gail E Henderson, Christine Rini, Myra I Roche, Fuki M Hisama,[...]. Genet. Med. 2017
20
50

Management of Secondary Genomic Findings.
Alexander E Katz, Robert L Nussbaum, Benjamin D Solomon, Heidi L Rehm, Marc S Williams, Leslie G Biesecker. Am J Hum Genet 2020
1
100

Genomic cloud computing: legal and ethical points to consider.
Edward S Dove, Yann Joly, Anne-Marie Tassé, Bartha M Knoppers. Eur. J. Hum. Genet. 2015
31
50

Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
Michael P Mackley, Benjamin Fletcher, Michael Parker, Hugh Watkins, Elizabeth Ormondroyd. Genet. Med. 2017
49
50


Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness.
Zornitza Stark, Deborah Schofield, Melissa Martyn, Luke Rynehart, Rupendra Shrestha, Khurshid Alam, Sebastian Lunke, Tiong Y Tan, Clara L Gaff, Susan M White. Genet. Med. 2019
42
50

Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial.
Salma Shickh, Marc Clausen, Chloe Mighton, Selina Casalino, Esha Joshi, Emily Glogowski, Kasmintan A Schrader, Adena Scheer, Christine Elser, Seema Panchal,[...]. BMJ Open 2018
12
50




Telegenetics: a systematic review of telemedicine in genetics services.
Jennifer S Hilgart, Julie A Hayward, Bernadette Coles, Rachel Iredale. Genet. Med. 2012
63
50

Policy challenges of clinical genome sequencing.
Caroline F Wright, Anna Middleton, Hilary Burton, Fiona Cunningham, Steve E Humphries, Jane Hurst, Ewan Birney, Helen V Firth. BMJ 2013
35
50


Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4.
Jonathan Karnon, James Stahl, Alan Brennan, J Jaime Caro, Javier Mar, Jörgen Möller. Value Health 2012
96
50

Genomics, Health Disparities, and Missed Opportunities for the Nation's Research Agenda.
Kathleen McGlone West, Erika Blacksher, Wylie Burke. JAMA 2017
29
50


The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists.
Kym Boycott, Taila Hartley, Shelin Adam, Francois Bernier, Karen Chong, Bridget A Fernandez, Jan M Friedman, Michael T Geraghty, Stacey Hume, Bartha M Knoppers,[...]. J. Med. Genet. 2015
95
50

p53 and Me.
Shekinah N C Elmore. N. Engl. J. Med. 2018
3
50

Patients-in-waiting: Living between sickness and health in the genomics era.
Stefan Timmermans, Mara Buchbinder. J Health Soc Behav 2010
111
50

Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics.
Carla G van El, Martina C Cornel, Pascal Borry, Ros J Hastings, Florence Fellmann, Shirley V Hodgson, Heidi C Howard, Anne Cambon-Thomsen, Bartha M Knoppers, Hanne Meijers-Heijboer,[...]. Eur. J. Hum. Genet. 2013
180
50

Analysis of laboratory reporting practices using a quality assessment of a virtual patient.
Danya F Vears, Martin Elferink, Marjolein Kriek, Pascal Borry, Koen L van Gassen. Genet Med 2020
1
100

Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD.
Katrina A Andrews, David B Ascher, Douglas Eduardo Valente Pires, Daniel R Barnes, Lindsey Vialard, Ruth T Casey, Nicola Bradshaw, Julian Adlard, Simon Aylwin, Paul Brennan,[...]. J. Med. Genet. 2018
53
50

Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years.
Anne Andermann, Ingeborg Blancquaert, Sylvie Beauchamp, Véronique Déry. Bull. World Health Organ. 2008
318
50

Ethical values supporting the disclosure of incidental and secondary findings in clinical genomic testing: a qualitative study.
Marlies Saelaert, Heidi Mertes, Tania Moerenhout, Elfride De Baere, Ignaas Devisch. BMC Med Ethics 2020
2
50


Searching for secondary findings: considering actionability and preserving the right not to know.
Bertrand Isidor, Sophie Julia, Pascale Saugier-Veber, Paul-Loup Weil-Dubuc, Stéphane Bézieau, Eric Bieth, Jean-Paul Bonnefont, Arnold Munnich, Franck Bourdeaut, Catherine Bourgain,[...]. Eur. J. Hum. Genet. 2019
3
50

Recontacting patients in clinical genetics services: recommendations of the European Society of Human Genetics.
Daniele Carrieri, Heidi C Howard, Caroline Benjamin, Angus J Clarke, Sandi Dheensa, Shane Doheny, Naomi Hawkins, Tanya F Halbersma-Konings, Leigh Jackson, Hülya Kayserili,[...]. Eur. J. Hum. Genet. 2019
18
50

Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Hartmut P H Neumann, Christian Pawlu, Mariola Peczkowska, Birke Bausch, Sarah R McWhinney, Mihaela Muresan, Mary Buchta, Gerlind Franke, Joachim Klisch, Thorsten A Bley,[...]. JAMA 2004
574
50

1 in 38 individuals at risk of a dominant medically actionable disease.
Lonneke Haer-Wigman, Vyne van der Schoot, Ilse Feenstra, Anneke T Vulto-van Silfhout, Christian Gilissen, Han G Brunner, Lisenka E L M Vissers, Helger G Yntema. Eur. J. Hum. Genet. 2019
13
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.